ArticleScientific reports2022
Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia.
Maddalena Marconato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it